{"id":12048,"date":"2026-10-21T14:23:24","date_gmt":"2026-10-21T18:23:24","guid":{"rendered":"https:\/\/crassulapharma.com\/?page_id=12048"},"modified":"2026-10-21T14:40:28","modified_gmt":"2026-10-21T18:40:28","slug":"vascutan","status":"publish","type":"page","link":"https:\/\/crassulapharma.com\/es\/vascutan\/","title":{"rendered":"Vascutan"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"12048\" class=\"elementor elementor-12048\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-c540f34 e-con-full e-flex e-con e-parent\" data-id=\"c540f34\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9dfbd92 elementor-widget elementor-widget-html\" data-id=\"9dfbd92\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!doctype html>\n<html lang=\"en\">\n<head>\n<meta charset=\"utf-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n<title>Vascutan\u00ae (Irbesartan) \u2013 Crassula<\/title>\n<meta name=\"description\" content=\"Vascutan contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration.\">\n<link rel=\"preload\" href=\"fonts\/poppins-latin-600-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<link rel=\"preload\" href=\"fonts\/ibm-plex-sans-latin-400-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<style>\n@font-face{font-family:\"Poppins\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-500-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"Poppins\";font-weight:600;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-600-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:400;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-400-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-500-normal.woff2) format(\"woff2\")}\n\n:root{\n  --teal-deep:#0d1c36; --teal-head:#1e3a6d; --teal:#2f4d82; --teal-2:#4f73ab; --teal-3:#162a50;\n  --red:#e36e33; --accent-text:#bf5421; --green:#5ba646;\n  --action-teal:#2f4d82; --ink:#1b2433; --ink-muted:#4a5a70; --surface:#f3f7fa; --note:#f3f7fa;\n  --line:#dce6ee;\n  --ease-out:cubic-bezier(.23,1,.32,1);\n  --font-head:\"Poppins\",system-ui,sans-serif;\n  --font-body:\"IBM Plex Sans\",system-ui,sans-serif;\n  --cx-gutter:clamp(20px,5vw,48px);\n  --cx-max:1120px;\n}\n*{box-sizing:border-box;margin:0}\nhtml{scroll-behavior:smooth;scroll-padding-top:24px;-webkit-text-size-adjust:100%}\nbody{font-family:var(--font-body);font-size:17px;line-height:1.6;color:var(--ink);background:#fff;-webkit-font-smoothing:antialiased;text-rendering:optimizeLegibility}\nimg{max-width:100%;height:auto;display:block}\na{color:var(--action-teal)}\n:focus-visible{outline:2px solid var(--action-teal);outline-offset:2px;border-radius:6px}\n.skip{position:absolute;left:12px;top:-60px;background:var(--ink);color:#fff;padding:10px 16px;border-radius:999px;z-index:100;text-decoration:none;font-family:var(--font-head);font-weight:500}\n.skip:focus{top:12px}\n.cx-wrap{width:100%;max-width:var(--cx-max);margin-inline:auto;padding-inline:var(--cx-gutter)}\n\n\/* Buttons *\/\n.btn{white-space:nowrap;display:inline-flex;align-items:center;justify-content:center;gap:8px;min-height:48px;padding:16px 28px;border-radius:6px;font:500 16px\/1 var(--font-head);text-decoration:none;cursor:pointer;border:1.5px solid transparent;\n  transition:background-color 150ms var(--ease-out),transform 150ms var(--ease-out),box-shadow 150ms var(--ease-out),color 150ms var(--ease-out)}\n.btn:active{transform:scale(.97)}\n.btn-primary{background:#fff;color:var(--teal-deep)}\n.btn-secondary{background:transparent;border-color:rgba(255,255,255,.85);color:#fff}\n.btn-sm{padding:12px 22px;min-height:48px;font-size:15px}\n@media (hover:hover) and (pointer:fine){\n  .btn-primary:hover{background:#e3ecf5;transform:translateY(-2px)}\n  .btn-secondary:hover{background:#fff;color:var(--teal-deep);transform:translateY(-2px)}\n}\n\n\/* Hero *\/\n.hero{position:relative;background:linear-gradient(125deg,#0d1c36 0%,#162a50 50%,#4f73ab 100%);overflow:hidden;isolation:isolate;color:#fff}\n.hero::before{content:\"\";position:absolute;inset:0;z-index:-1;background:repeating-linear-gradient(115deg,rgba(255,255,255,.045) 0 1px,transparent 1px 46px)}\n.hero canvas{position:absolute;inset:0;width:100%;height:100%;z-index:-1;pointer-events:none}\n.hero::after{content:\"\";position:absolute;left:-6%;right:-6%;bottom:-1px;height:clamp(36px,6vw,70px);background:#fff;border-radius:50% 50% 0 0\/100% 100% 0 0}\n.hero .cx-wrap{display:grid;grid-template-columns:1fr 1fr;align-items:center;gap:clamp(24px,4vw,48px);padding-block:clamp(50px,8vw,50px) clamp(96px,11vw,132px)}\n.tag{display:inline-block;font:500 12px\/1 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:#fff;border:1px solid rgba(255,255,255,.4);border-radius:6px;padding:11px 16px;background:rgba(255,255,255,.08);margin-bottom:28px}\nh1{font:600 clamp(40px,7vw,64px)\/1.08 var(--font-head);letter-spacing:-.02em;color:#fff}\nh1 sup{font-size:.34em;vertical-align:top;position:relative;top:.55em;margin-left:.08em;letter-spacing:0}\n.generic{font:500 clamp(22px,3vw,28px)\/1.3 var(--font-head);color:rgba(255,255,255,.88);margin-top:10px}\n.strengths{display:flex;gap:10px;margin-top:26px;flex-wrap:wrap}\n.chip{font:600 20px\/1 var(--font-head);padding:12px 20px;border-radius:12px;color:#fff;font-variant-numeric:tabular-nums}\n.chip.t{background:#fff;color:var(--teal-head)}.chip.g{background:var(--red)}\n.cta-row{display:flex;gap:12px;flex-wrap:wrap;margin-top:36px}\n.hero-art{position:relative;width:100%;display:grid;place-items:center}\n.hero-art img{width:100%;max-width:640px;height:auto}\n@media (max-width:860px){.hero .cx-wrap{grid-template-columns:1fr}.hero-art{max-width:600px;width:100%;margin:0 auto}}\n\n\/* Spec strip *\/\n.specs{margin-top:-70px;position:relative;z-index:2}\n.specs ul{list-style:none;padding:0;display:grid;grid-template-columns:repeat(4,1fr);background:#fff;border:1px solid var(--line);border-radius:20px;box-shadow:0 14px 34px -18px rgba(13,28,54,.30)}\n.specs ul{overflow:hidden}\n.specs li{position:relative;transition:background-color 250ms var(--ease-out),transform 250ms var(--ease-out);display:flex;align-items:center;gap:14px;padding:22px 24px;border-left:1px solid var(--line)}\n.specs li:first-child{border-left:0}\n.specs li::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:3px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 350ms var(--ease-out)}\n.specs .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n.specs dd{transition:transform 300ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .specs li:hover{background:var(--note)}\n  .specs li:hover::after{transform:scaleX(1)}\n  .specs li:hover .ico{transform:translateY(-3px) scale(1.12) rotate(-6deg);background:var(--teal-deep);box-shadow:0 10px 18px -8px rgba(13,28,54,.55)}\n  .specs li:hover dd{color:var(--teal);transform:translateX(3px)}\n}\n.ico{flex:none;width:42px;height:42px;border-radius:50%;background:var(--action-teal);display:grid;place-items:center;color:#fff}\n.ico svg{width:20px;height:20px;stroke:currentColor;fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round}\n.specs dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.specs dd{font:600 15.5px\/1.3 var(--font-head);margin-top:4px;color:var(--ink)}\n@media (max-width:900px){.specs ul{grid-template-columns:1fr 1fr}.specs li:nth-child(3){border-left:0}.specs li:nth-child(n+3){border-top:1px solid var(--line)}}\n@media (max-width:480px){.specs ul{grid-template-columns:1fr}.specs li{border-left:0!important}.specs li+li{border-top:1px solid var(--line)}}\n\n\/* Sections *\/\nsection{padding-block:clamp(56px,8vw,96px)}\n.h2{color:var(--teal-head);display:flex;align-items:center;gap:14px;font:600 clamp(28px,4vw,36px)\/1.15 var(--font-head);letter-spacing:-.01em;margin-bottom:28px}\n.h2::before{content:\"\";flex:none;width:6px;align-self:stretch;min-height:1.1em;border-radius:4px;background:linear-gradient(var(--teal-2),var(--green))}\n.prose p{max-width:68ch;color:var(--ink)}\n.prose p+p{margin-top:14px}\n.prose strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.about{padding-top:clamp(64px,9vw,104px)}\n\n\/* Indications *\/\n.indications{background:#fff;padding-top:0}\n.cards{display:grid;grid-template-columns:repeat(2,1fr);gap:20px}\n.card{background:var(--surface);border:1px solid var(--line);border-radius:20px;padding:28px;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out),border-color 250ms var(--ease-out)}\n.card{position:relative;overflow:hidden}\n.card::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:4px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 400ms var(--ease-out)}\n.card .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .card:hover{transform:translateY(-8px);box-shadow:0 24px 40px -22px rgba(13,28,54,.45);border-color:#a9bfd8;background:#fff}\n  .card:hover::after{transform:scaleX(1)}\n  .card:hover .ico{background:var(--teal);color:#fff;transform:rotate(-8deg) scale(1.12)}\n}\n.card .ico{width:38px;height:38px;background:#fff;color:var(--action-teal);border:1px solid var(--line);border-radius:12px;margin-bottom:18px}\n.card h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin-bottom:10px}\n.card p{color:var(--ink-muted);font-size:16.5px}\n.card em{font-style:italic}\n@media (max-width:760px){.cards{grid-template-columns:1fr}}\n\n\/* Presentations *\/\n.presentations{background:var(--surface)}\n.pres{display:grid;grid-template-columns:1fr 1fr;gap:20px}\n.pcard{display:flex;align-items:center;gap:24px;background:#fff;border:1px solid var(--line);border-radius:20px;padding:26px 28px;position:relative;overflow:hidden;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out)}\n.pcard::before{content:\"\";position:absolute;left:0;top:0;bottom:0;width:6px;background:var(--c)}\n.pcard::before{transition:width 300ms var(--ease-out)}\n.dose{transition:transform 350ms var(--ease-out)}\n@media (hover:hover){\n  .pcard:hover{transform:translateY(-6px);box-shadow:0 24px 40px -22px rgba(13,28,54,.45)}\n  .pcard:hover::before{width:14px}\n  .pcard:hover .dose{transform:scale(1.08) translateX(4px)}\n}\n.dose{font:600 clamp(40px,6vw,52px)\/1 var(--font-head);color:var(--c);letter-spacing:-.02em;white-space:nowrap}\n.dose small{font:500 18px\/1 var(--font-head);letter-spacing:0;margin-left:4px}\n.pcard h3{color:var(--teal-head);font:600 17px\/1.35 var(--font-head);margin-bottom:6px}\n.pcard p{color:var(--ink-muted);font-size:16px;line-height:1.5}\n@media (max-width:760px){.pres{grid-template-columns:1fr}}\n\n\/* Mechanism *\/\n.mech-intro{max-width:78ch;margin-bottom:44px}\n.mech-intro strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.mech-grid{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,64px);align-items:start}\n.steps{list-style:none;padding:0;position:relative}\n.steps::before{content:\"\";position:absolute;left:19px;top:20px;bottom:30px;width:2px;background:linear-gradient(var(--action-teal),rgba(47,77,130,.08));transform-origin:top;transform:scaleY(var(--line,0));transition:transform 900ms var(--ease-out)}\n.steps li{position:relative;padding-left:64px;padding-bottom:34px;transition:transform 300ms var(--ease-out)}\n.num{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out)}\n.steps h3{transition:color 250ms var(--ease-out)}\n@media (hover:hover){.steps li:hover{transform:translateX(6px)}.steps li:hover .num{transform:scale(1.18);background:var(--teal-deep)}.steps li:hover h3{color:var(--teal)}}\n.steps li:last-child{padding-bottom:0}\n.num{position:absolute;left:0;top:0;width:40px;height:40px;border-radius:50%;background:var(--action-teal);color:#fff;display:grid;place-items:center;font:600 16px\/1 var(--font-head);box-shadow:0 0 0 5px #fff}\n.steps h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin:6px 0 6px}\n.steps p{color:var(--ink-muted)}\n@media (max-width:900px){.mech-grid{grid-template-columns:1fr}}\n\n\/* Flow diagram *\/\n.flow{background:var(--surface);border:1px solid var(--line);border-radius:24px;padding:28px clamp(18px,3vw,32px) 32px;text-align:center}\n.flow-title{font:600 12px\/1 var(--font-body);letter-spacing:.14em;text-transform:uppercase;color:var(--ink-muted);margin-bottom:22px}\n.node{display:block;margin-inline:auto;background:#fff;border:1.5px solid #c5d5e6;border-radius:12px;padding:10px 16px;max-width:300px;font:600 14px\/1.3 var(--font-head);color:var(--ink);opacity:0;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n.node small{display:block;font:400 12px\/1.3 var(--font-body);color:var(--ink-muted);margin-top:2px}\n.node.primary{background:var(--action-teal);border-color:var(--action-teal);color:#fff;border-radius:999px;padding:14px 20px;font-size:16px}\n.node.primary small{color:#fff;font-size:12.5px}\n.node.end{background:var(--action-teal);border-color:var(--action-teal);color:#fff;padding:14px 18px;font-size:15px}\n.flow.in .node{opacity:1;animation:rise 450ms var(--ease-out) backwards;animation-delay:calc(var(--i)*220ms)}\n@media (hover:hover){.flow.in .node:hover{transform:translateY(-3px) scale(1.03);border-color:var(--teal);box-shadow:0 10px 20px -12px rgba(13,28,54,.45)}}\n.link-v{display:flex;flex-direction:column;align-items:center;height:30px;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .link-v{opacity:1}\n.link-v::before{content:\"\";flex:1;width:2px;background:var(--action-teal)}\n.link-v::after{content:\"\";width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.link-v.stop::after{border:0;width:22px;height:2px;background:var(--red)}\n.link-v.stop::before{background:var(--red)}\n.link-v.stop span{position:absolute;left:calc(50% + 14px);top:50%;transform:translateY(-50%);font:400 11.5px\/1 var(--font-body);color:var(--accent-text)}\n.pair{display:grid;grid-template-columns:1fr 1fr;gap:10px;max-width:340px;margin-inline:auto}\n.pair .node{max-width:none;font-size:13px;padding:10px 10px}\n.fork{max-width:340px;height:28px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .fork{opacity:1}\n.fork::before{content:\"\";position:absolute;left:25%;right:25%;top:0;height:14px;border:2px solid var(--action-teal);border-bottom:0;border-radius:0}\n.fork::after{content:\"\";position:absolute;left:50%;top:-14px;height:14px;width:2px;background:var(--action-teal)}\n.fork i{position:absolute;top:14px;width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.fork i:first-child{left:calc(25% - 6px)}.fork i:last-child{right:calc(25% - 6px)}\n.pair-wrap{display:grid;gap:10px}\n.down-merge{margin-top:2px}\n\n\n\/* Product additions *\/\n.pcard.wide{display:grid;grid-template-columns:auto 1fr;gap:clamp(20px,4vw,48px)}\n.pgrid{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pgrid dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.pgrid dd{font:600 16px\/1.35 var(--font-head);color:var(--teal-head);margin-top:6px}\n@media (max-width:760px){.pcard.wide{grid-template-columns:1fr;gap:16px}.pgrid{grid-template-columns:1fr}}\n.dn{color:var(--red);font-weight:600}\n.node.end.clock{display:flex;align-items:center;justify-content:center;gap:12px;max-width:260px;margin-top:14px;text-align:left;padding:12px 18px}\n.node.end.clock svg{flex:none;width:34px;height:34px;padding:7px;border-radius:50%;background:var(--red);stroke:#fff;fill:none;stroke-width:2;stroke-linecap:round;stroke-linejoin:round}\n.node.end.clock b{display:block;font:600 15px\/1.2 var(--font-head)}\n.node.end.clock small{color:#fff;opacity:.92;font-size:12px;margin-top:2px}\n.pair{margin-top:0}\n.steps p sup{font-size:.7em;line-height:0}\n\n\n\/* Media + FAQ additions *\/\n.split{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,72px);align-items:center}\n.split.rev{grid-template-columns:.9fr 1.1fr}\n.media-wrap{position:relative;isolation:isolate}\n.media-wrap::before{content:\"\";position:absolute;right:-14px;bottom:-14px;width:62%;height:62%;border-radius:26px;background:linear-gradient(135deg,var(--teal-2),var(--green));opacity:.2;z-index:-1;transition:transform 500ms var(--ease-out),opacity 500ms var(--ease-out)}\n.split.rev .media-wrap::before{right:auto;left:-14px}\n.media{position:relative;border-radius:24px;overflow:hidden;aspect-ratio:4\/4;background:var(--surface)}\n.media img{width:100%;height:100%;object-fit:cover;display:block;transition:transform 900ms var(--ease-out)}\n@media (hover:hover){.media-wrap:hover .media img{transform:scale(1.05)}.media-wrap:hover::before{transform:translate(6px,6px);opacity:.32}.split.rev .media-wrap:hover::before{transform:translate(-6px,6px)}}\n@media (max-width:860px){.split,.split.rev{grid-template-columns:1fr}.split.rev .media-wrap{order:2}.media-wrap{max-width:560px}}\n.faq{background:var(--surface)}\n.faq-list{display:grid;gap:12px;max-width:880px}\n.faq-item{background:#fff;border:1px solid var(--line);border-radius:16px;overflow:hidden;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n@media (hover:hover){.faq-item:hover{transform:translateY(-2px);border-color:#a9bfd8;border-color:color-mix(in srgb,var(--teal-2) 40%,var(--line));box-shadow:0 16px 30px -22px rgba(13,28,54,.4)}}\n.faq-item.open{border-color:var(--teal-2);box-shadow:0 18px 34px -24px rgba(13,28,54,.45)}\n.faq-q{width:100%;display:flex;align-items:center;justify-content:space-between;gap:16px;min-height:48px;padding:20px 24px;background:none;border:0;cursor:pointer;text-align:left;font:600 17px\/1.4 var(--font-head);color:var(--teal-head)}\n.faq-q:focus-visible{outline-offset:-4px}\n.faq-ico{flex:none;width:34px;height:34px;border-radius:10px;background:var(--surface);display:grid;place-items:center;transition:background-color 250ms var(--ease-out),transform 350ms var(--ease-out)}\n.faq-ico svg{width:16px;height:16px;stroke:var(--teal);stroke-width:2.2;stroke-linecap:round;fill:none;transition:stroke 250ms var(--ease-out)}\n.faq-item.open .faq-ico{background:var(--teal);transform:rotate(45deg)}\n.faq-item.open .faq-ico svg{stroke:#fff}\n.faq-a{display:grid;grid-template-rows:0fr;transition:grid-template-rows 350ms var(--ease-out)}\n.faq-item.open .faq-a{grid-template-rows:1fr}\n.faq-a>div{overflow:hidden;visibility:hidden;transition:visibility 0s linear 350ms}\n.faq-item.open .faq-a>div{visibility:visible;transition-delay:0s}\n.faq-a p{padding:0 24px 22px;max-width:70ch;color:var(--ink-muted)}\n.faq-a p+p{padding-top:0;margin-top:-8px}\n\n\n\/* Note with background image *\/\n.note-box.has-bg{position:relative;overflow:hidden;isolation:isolate;border:0;color:#fff;min-height:260px;display:flex;flex-direction:column;justify-content:center;padding:clamp(32px,5vw,64px)}\n.note-box.has-bg .bg{position:absolute;inset:0;z-index:-2;overflow:hidden}\n.note-box.has-bg .bg img{width:100%;height:100%;object-fit:cover;object-position:0% 100%;display:block;transform:scale(1.02);transition:transform 1000ms var(--ease-out)}\n.note-box.has-bg::after{content:\"\";position:absolute;inset:0;z-index:-1;background:linear-gradient(100deg,rgba(var(--ov),.93) 0%,rgba(var(--ov),.86) 60%,rgba(var(--ov),.78) 100%)}\n.note-box.has-bg h3{color:#fff}\n.note-box.has-bg h3 .ico{background:rgba(255,255,255,.16);box-shadow:inset 0 0 0 1px rgba(255,255,255,.28)}\n.note-box.has-bg p{color:#fff;max-width:72ch;font-size:17.5px}\n.note-box.has-bg p::before{background:var(--green)}\n@media (hover:hover){.note-box.has-bg:hover .bg img{transform:scale(1.08)}}\n\/* Rounded-corner fix: clip every layer to the radius so hover scale never squares the corners *\/\n.note-box.has-bg{border-radius:20px;clip-path:inset(0 round 20px)}\n@media (hover:hover){.note-box.has-bg:hover{transform:translate3d(0,-4px,0);box-shadow:none}}\n.note-box.has-bg .bg,.note-box.has-bg .bg img,.note-box.has-bg::after{border-radius:20px}\n.note-box.has-bg .bg img{will-change:transform}\n\n\n\/* Note *\/\n.note{padding-block:0 clamp(40px,6vw,64px)}\n.note-box{background:var(--note);border:1px solid #dce6ee;border-radius:20px;padding:26px clamp(20px,3vw,32px)}\n.note-box{transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n@media (hover:hover){.note-box:hover{transform:translateY(-4px);box-shadow:0 22px 38px -26px rgba(13,28,54,.5)}}\n.note-box h3{color:var(--teal-head);display:flex;align-items:center;gap:12px;font:600 19px\/1.2 var(--font-head);margin-bottom:12px}\n.note-box h3 .ico{width:38px;height:38px;border-radius:12px;background:var(--action-teal)}\n.note-box p{position:relative;padding-left:20px;color:var(--ink)}\n.note-box p::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n\n\/* Quality *\/\n.quality{padding-top:96px}\n.qbox{border:1px solid var(--line);border-radius:20px;padding:clamp(22px,3vw,34px);box-shadow:0 14px 34px -24px rgba(14,42,51,.25)}\n.qbox h2{font:600 22px\/1.2 var(--font-head);margin-bottom:24px}\n.qgrid{display:grid;grid-template-columns:auto 1fr 1fr;gap:clamp(20px,3vw,40px);align-items:center}\n.gmp{width:112px;height:112px;object-fit:contain;flex:none;filter:drop-shadow(0 6px 12px rgba(13,28,54,.18));transition:transform 500ms var(--ease-out),filter 500ms var(--ease-out)}\n@media (hover:hover){.gmp:hover{transform:scale(1.08);filter:drop-shadow(0 10px 18px rgba(13,28,54,.24))}}\n.check{display:flex;gap:14px;color:var(--ink-muted);font-size:16px;line-height:1.55}\n.check{transition:transform 300ms var(--ease-out)}\n@media (hover:hover){.check:hover{transform:translateY(-4px)}.check:hover svg{transform:scale(1.18) rotate(-6deg)}}\n.check svg{transition:transform 300ms var(--ease-out);flex:none;width:26px;height:26px;stroke:var(--green);fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round;margin-top:2px}\n@media (max-width:900px){.qgrid{grid-template-columns:1fr;align-items:start}}\n\n\/* Reveal *\/\n.rv{opacity:0}\n.rv.in{opacity:1;animation:rise 600ms var(--ease-out) backwards;animation-delay:calc(var(--d,0)*80ms)}\n@keyframes rise{from{opacity:0;transform:translateY(18px)}to{opacity:1;transform:none}}\n.hero-art img{opacity:0;transition:opacity 700ms var(--ease-out),transform 900ms var(--ease-out)}\n.loaded .hero-art img{opacity:1;transform:none}\n@keyframes bob{0%,100%{translate:0 0}50%{translate:0 -8px}}\n.hero-art img{transform:translate(30px,24px) rotate(2deg)}\n.loaded .hero-art img{animation:bob 7s ease-in-out 1.2s infinite}\n.hero-copy>*{opacity:0;transform:translateY(14px);transition:opacity 600ms var(--ease-out),transform 600ms var(--ease-out)}\n.loaded .hero-copy>*{opacity:1;transform:none}\n.loaded .hero-copy>:nth-child(2){transition-delay:70ms}.loaded .hero-copy>:nth-child(3){transition-delay:140ms}.loaded .hero-copy>:nth-child(4){transition-delay:210ms}.loaded .hero-copy>:nth-child(5){transition-delay:280ms}\n\n@media (prefers-reduced-motion:reduce){\n  html{scroll-behavior:auto}\n  *,*::before,*::after{animation:none!important;transition-duration:.01ms!important;transition-delay:0ms!important}\n  .rv,.hero-copy>*,.hero-art img,.node,.link-v,.fork,.join{opacity:1!important;transform:none!important}\n  .steps{--line:1!important}\n}\n.no-js .rv,.no-js .hero-copy>*,.no-js .hero-art img,.no-js .node,.no-js .link-v,.no-js .fork,.no-js .join{opacity:1;transform:none}\n.no-js .steps{--line:1}\n\n\/* Vascutan additions *\/\n.cards.c3{grid-template-columns:repeat(3,1fr)}\n@media (max-width:900px){.cards.c3{grid-template-columns:1fr}}\n.card-h{display:flex;align-items:center;gap:14px;margin-bottom:10px}\n.card-h .ico{margin-bottom:0;flex:none}\n.card-h h3{margin-bottom:0}\n.lead{max-width:80ch;margin-bottom:28px;color:var(--ink)}\n.cards.c2 .card.wide{grid-column:1\/-1}\n.cards.c2{margin-bottom:20px}\n.card ul{list-style:none;padding:0;display:grid;gap:10px}\n.card li{position:relative;padding-left:20px;color:var(--ink-muted);font-size:16.5px}\n.card li::before{content:\"\";position:absolute;left:0;top:.65em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n.card.sol li::before{background:var(--teal-2)}\n.card.wide ul{grid-template-columns:repeat(3,1fr);gap:18px 28px}\n@media (max-width:900px){.card.wide ul{grid-template-columns:1fr}}\n.pair.pad{max-width:340px}\n.join{max-width:340px;height:16px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .join{opacity:1}\n.join::before{content:\"\";position:absolute;left:25%;right:25%;bottom:0;height:16px;border:2px solid var(--action-teal);border-top:0}\n.join::after{content:\"\";position:absolute;left:50%;bottom:-14px;height:14px;width:2px;background:var(--action-teal)}\n.node.end small{color:#fff;opacity:.92}\n.dn{color:var(--red);font-weight:600}\n.note-box.has-bg li{color:#fff}\n.note-box.has-bg ul{list-style:none;padding:0;display:grid;gap:12px;max-width:72ch}\n.note-box.has-bg li{position:relative;padding-left:20px;font-size:17.5px;line-height:1.6}\n.note-box.has-bg li::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:var(--red)}\n.note-box.has-bg h3 .ico{background:rgba(255,255,255,.16)}\n[type=\"button\"]:hover{background-color:transparent;color:var(--teal-head)}\n[type=\"button\"]:focus{background-color:transparent;color:var(--teal-head)}\n<\/style>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"What is Vascutan?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated for the treatment of essential hypertension in adults and for the treatment of renal disease in adults with hypertension and type 2 diabetes mellitus as part of an antihypertensive treatment regimen.\"}}, {\"@type\": \"Question\", \"name\": \"What is Vascutan indicated for?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan is indicated for the treatment of arterial hypertension in adults and may be used as part of a combination treatment when other medications are not sufficient. It is suitable for arterial hypertension (to control high blood pressure), renal disease in type 2 diabetes (treatment of renal disease in adults with hypertension and type 2 diabetes mellitus) and 24-hour blood pressure control (effective blood pressure control over 24 hours with once-daily dosing).\"}}, {\"@type\": \"Question\", \"name\": \"How does Vascutan work?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Irbesartan is an angiotensin II receptor antagonist, effective in relaxing the blood vessels and lowering blood pressure. It not only controls blood pressure but also offers renal protection in patients with type 2 diabetes.\"}}, {\"@type\": \"Question\", \"name\": \"How is Vascutan dosed and administered?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The dose should be adjusted individually according to the severity of hypertension and the patient\u2019s response. Typical starting dose: 150 mg once daily, with adjustments up to 300 mg according to the patient\u2019s response. Can be administered with or without food.\"}}, {\"@type\": \"Question\", \"name\": \"What are the benefits of Vascutan?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The use of Irbesartan in Vascutan can significantly reduce blood pressure without causing an increase in heart rate. Facilitates the long-term management of hypertension with a low side-effect profile.\"}}, {\"@type\": \"Question\", \"name\": \"What are the clinical considerations for Vascutan?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Evaluate blood pressure and renal function before starting treatment. Adjust the dose based on the patient\u2019s blood pressure response. Monitor renal function regularly, especially in patients with cardiorenal diseases.\"}}, {\"@type\": \"Question\", \"name\": \"What are the safety and precautionary measures for Vascutan?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Monitor blood pressure regularly to ensure the effectiveness of the treatment. Use with caution in patients with fluid volume or salt disturbances. Contraindicated in patients with known hypersensitivity to irbesartan or with bilateral renal artery stenosis.\"}}, {\"@type\": \"Question\", \"name\": \"Which strength and presentation is available?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan contains irbesartan 300 mg, oral, and comes in a box of 30 or 100 tablets, following the United States Pharmacopeia standard.\"}}, {\"@type\": \"Question\", \"name\": \"How is Vascutan manufactured?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan is manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all its products are manufactured in accordance with GMP parameters.\"}}]}<\/script>\n<\/head>\n<body class=\"no-js\">\n<a class=\"skip\" href=\"#main\">Skip to content<\/a>\n<span id=\"top\"><\/span>\n\n\n<main id=\"main\">\n<section class=\"hero\" aria-labelledby=\"h1\" style=\"padding:0\">\n  <canvas id=\"fx\" aria-hidden=\"true\"><\/canvas>\n  <div class=\"cx-wrap\">\n    <div class=\"hero-copy\">\n      <span class=\"tag\">Angiotensin II Receptor Antagonist \u00b7 Hypertension<\/span>\n      <h1 id=\"h1\">Vascutan<sup>\u00ae<\/sup><\/h1>\n      <p class=\"generic\">Irbesartan<\/p>\n      <div class=\"strengths\" role=\"list\">\n        <span class=\"chip g\" role=\"listitem\">300 mg<\/span>\n      <\/div>\n      <div class=\"cta-row\">\n        <a class=\"btn btn-primary\" href=\"#mechanism\">Pharmacological Properties<\/a>\n      <\/div>\n    <\/div>\n    <div class=\"hero-art\">\n      <img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/box-vascutan.png\" alt=\"Vascutan irbesartan 300 mg box\" width=\"1301\" height=\"959\" title=\"\">\n    <\/div>\n  <\/div>\n<\/section>\n\n<div class=\"specs\">\n  <div class=\"cx-wrap\">\n    <ul>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.5\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><dl><dt>Active ingredient<\/dt><dd>Irbesartan 300 mg<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M9 3h6v3H9zM8 6h8v3a4 4 0 0 1-8 0V6Z\"\/><path d=\"M12 13v8\"\/><\/svg><\/span><dl><dt>Route<\/dt><dd>Oral<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M21 8 12 3 3 8v8l9 5 9-5V8Z\"\/><path d=\"m3 8 9 5 9-5M12 13v8\"\/><\/svg><\/span><dl><dt>Presentation<\/dt><dd>Box of 30 or 100 tablets<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"5\" y=\"3\" width=\"14\" height=\"18\" rx=\"3\"\/><path d=\"M9 8h6M9 12h6M9 16h3\"\/><\/svg><\/span><dl><dt>Standard<\/dt><dd>USP<\/dd><\/dl><\/li>\n    <\/ul>\n  <\/div>\n<\/div>\n\n<section class=\"about\" aria-labelledby=\"what\">\n  <div class=\"cx-wrap split\">\n    <div class=\"prose rv\">\n    <h2 class=\"h2\" id=\"what\">What is Vascutan?<\/h2>\n    <p><strong>Vascutan<\/strong> contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated for the treatment of essential hypertension in adults and for the treatment of renal disease in adults with hypertension and type 2 diabetes mellitus as part of an antihypertensive treatment regimen.<\/p>\n    <\/div>\n    <div class=\"media-wrap rv\" style=\"--d:1\"><div class=\"media\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-vascutan.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div><\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"indications\" aria-labelledby=\"ind\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"ind\">Indications<\/h2>\n    <p class=\"lead rv\">Vascutan is indicated for the treatment of arterial hypertension in adults and may be used as part of a combination treatment when other medications are not sufficient. It is suitable for treatment in the following conditions:<\/p>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M3 12h4l2.500-6 4 12 2.500-6h5\"\/><\/svg><\/span><h3>Arterial Hypertension<\/h3><\/div>\n        <p>To control high blood pressure.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M8 4c-2 2-3 5-2 8s3 5 3 8M16 4c2 2 3 5 2 8s-3 5-3 8\"\/><\/svg><\/span><h3>Renal Disease in Type 2 Diabetes<\/h3><\/div>\n        <p>Treatment of renal disease in adults with hypertension and type 2 diabetes mellitus.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 20s-7-4.500-7-10a4 4 0 0 1 7-2.500A4 4 0 0 1 19 10c0 5.500-7 10-7 10Z\"\/><path d=\"M8.500 11h2l1-2 1.500 4 1-2h1.500\"\/><\/svg><\/span><h3>24-Hour Blood Pressure Control<\/h3><\/div>\n        <p>Provides effective blood pressure control over 24 hours with once-daily dosing.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"presentations\" id=\"presentations\" aria-labelledby=\"pres\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"pres\">Presentation<\/h2>\n    <article class=\"pcard wide rv\" style=\"--c:var(--red)\">\n      <div class=\"dose\">300<small>mg<\/small><\/div>\n      <dl class=\"pgrid\">\n        <div><dt>Active ingredient<\/dt><dd>Irbesartan 300 mg<\/dd><\/div>\n        <div><dt>Presentation<\/dt><dd>Box of 30 or 100 tablets<\/dd><\/div>\n        <div><dt>Standard<\/dt><dd>United States Pharmacopeia<\/dd><\/div>\n      <\/dl>\n    <\/article>\n  <\/div>\n<\/section>\n\n<section id=\"mechanism\" aria-labelledby=\"moa\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"moa\">Pharmacological Properties<\/h2>\n    <div class=\"mech-grid\">\n      <ol class=\"steps\" id=\"steps\">\n        <li class=\"rv\"><span class=\"num\">1<\/span><h3>Angiotensin II Receptor Antagonist<\/h3><p>Irbesartan is an angiotensin II receptor antagonist, effective in relaxing the blood vessels and lowering blood pressure.<\/p><\/li>\n        <li class=\"rv\"><span class=\"num\">2<\/span><h3>Renal Protection<\/h3><p>It not only controls blood pressure but also offers renal protection in patients with type 2 diabetes.<\/p><\/li>\n      <\/ol>\n\n      <div class=\"flow\" id=\"flow\" role=\"group\" aria-label=\"How Vascutan works\">\n        <p class=\"flow-title\">How Vascutan works<\/p>\n        <span class=\"node primary\" style=\"--i:0\">Vascutan\u00ae<small>Irbesartan<\/small><\/span>\n        <div class=\"link-v stop\" style=\"--i:1\"><span>blocks<\/span><\/div>\n        <span class=\"node\" style=\"--i:2\">Angiotensin II receptor<\/span>\n        <div class=\"link-v\" style=\"--i:3\"><\/div>\n        <span class=\"node\" style=\"--i:4\">Relaxation of blood vessels<\/span>\n        <div class=\"fork\" style=\"--i:5\"><i><\/i><i><\/i><\/div>\n        <div class=\"pair\">\n          <span class=\"node\" style=\"--i:6\"><span class=\"dn\">\u2193<\/span> Blood pressure<\/span>\n          <span class=\"node\" style=\"--i:6\">Renal protection<small>(type 2 diabetes)<\/small><\/span>\n        <\/div>\n        <div style=\"height:12px\"><\/div>\n        <div class=\"join\" style=\"--i:7\"><\/div>\n        <div style=\"height:14px\"><\/div>\n        <span class=\"node end\" style=\"--i:8\">More efficient blood flow<\/span>\n      <\/div>\n    <\/div>\n\n    <div class=\"cards c2\" style=\"margin-top:56px\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 7v5l3 2\"\/><\/svg><\/span><h3>Dosage and Administration<\/h3><\/div>\n        <ul><li>The dose should be adjusted individually according to the severity of hypertension and the patient\u2019s response.<\/li><li>Typical starting dose: 150 mg once daily, with adjustments up to 300 mg according to the patient\u2019s response.<\/li><li>Can be administered with or without food.<\/li><\/ul>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.500\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><h3>Benefits of Vascutan<\/h3><\/div>\n        <ul><li>The use of Irbesartan in Vascutan can significantly reduce blood pressure without causing an increase in heart rate.<\/li><li>Facilitates the long-term management of hypertension with a low side-effect profile.<\/li><\/ul>\n      <\/article>\n      <article class=\"card wide rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M9 3h6M10 3v6l-5 9a2 2 0 0 0 1.800 3h10.400a2 2 0 0 0 1.800-3l-5-9V3\"\/><path d=\"M7.500 15h9\"\/><\/svg><\/span><h3>Clinical Considerations<\/h3><\/div>\n        <ul><li>Evaluate blood pressure and renal function before starting treatment.<\/li><li>Adjust the dose based on the patient\u2019s blood pressure response.<\/li><li>Monitor renal function regularly, especially in patients with cardiorenal diseases.<\/li><\/ul>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"note\" aria-labelledby=\"imp\">\n  <div class=\"cx-wrap\">\n    <div class=\"note-box has-bg rv\" style=\"--ov:13,28,54\">\n      <div class=\"bg\" aria-hidden=\"true\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-vascutan.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div>\n      <h3 id=\"imp\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 2.500 20h19L12 3Z\"\/><path d=\"M12 10v4.500M12 17.200v.1\"\/><\/svg><\/span>Safety and Precautionary Measures<\/h3>\n      <ul>\n        <li>Monitor blood pressure regularly to ensure the effectiveness of the treatment.<\/li>\n        <li>Use with caution in patients with fluid volume or salt disturbances.<\/li>\n        <li>Contraindicated in patients with known hypersensitivity to irbesartan or with bilateral renal artery stenosis.<\/li>\n      <\/ul>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"faq\" id=\"faq\" aria-labelledby=\"faq-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"faq-h\">Frequently Asked Questions<\/h2>\n    <div class=\"faq-list\">\n      <div class=\"faq-item rv\" style=\"--d:0\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q1\" aria-expanded=\"false\" aria-controls=\"faq-a1\"><span>What is Vascutan?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a1\" role=\"region\" aria-labelledby=\"faq-q1\"><div><p><strong>Vascutan<\/strong> contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated for the treatment of essential hypertension in adults and for the treatment of renal disease in adults with hypertension and type 2 diabetes mellitus as part of an antihypertensive treatment regimen.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:1\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q2\" aria-expanded=\"false\" aria-controls=\"faq-a2\"><span>What is Vascutan indicated for?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a2\" role=\"region\" aria-labelledby=\"faq-q2\"><div><p>Vascutan is indicated for the treatment of arterial hypertension in adults and may be used as part of a combination treatment when other medications are not sufficient. It is suitable for arterial hypertension (to control high blood pressure), renal disease in type 2 diabetes (treatment of renal disease in adults with hypertension and type 2 diabetes mellitus) and 24-hour blood pressure control (effective blood pressure control over 24 hours with once-daily dosing).<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:2\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q3\" aria-expanded=\"false\" aria-controls=\"faq-a3\"><span>How does Vascutan work?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a3\" role=\"region\" aria-labelledby=\"faq-q3\"><div><p>Irbesartan is an angiotensin II receptor antagonist, effective in relaxing the blood vessels and lowering blood pressure. It not only controls blood pressure but also offers renal protection in patients with type 2 diabetes.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:3\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q4\" aria-expanded=\"false\" aria-controls=\"faq-a4\"><span>How is Vascutan dosed and administered?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a4\" role=\"region\" aria-labelledby=\"faq-q4\"><div><p>The dose should be adjusted individually according to the severity of hypertension and the patient\u2019s response. Typical starting dose: 150 mg once daily, with adjustments up to 300 mg according to the patient\u2019s response. Can be administered with or without food.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q5\" aria-expanded=\"false\" aria-controls=\"faq-a5\"><span>What are the benefits of Vascutan?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a5\" role=\"region\" aria-labelledby=\"faq-q5\"><div><p>The use of Irbesartan in Vascutan can significantly reduce blood pressure without causing an increase in heart rate. Facilitates the long-term management of hypertension with a low side-effect profile.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q6\" aria-expanded=\"false\" aria-controls=\"faq-a6\"><span>What are the clinical considerations for Vascutan?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a6\" role=\"region\" aria-labelledby=\"faq-q6\"><div><p>Evaluate blood pressure and renal function before starting treatment. Adjust the dose based on the patient\u2019s blood pressure response. Monitor renal function regularly, especially in patients with cardiorenal diseases.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q7\" aria-expanded=\"false\" aria-controls=\"faq-a7\"><span>What are the safety and precautionary measures for Vascutan?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a7\" role=\"region\" aria-labelledby=\"faq-q7\"><div><p>Monitor blood pressure regularly to ensure the effectiveness of the treatment. Use with caution in patients with fluid volume or salt disturbances. Contraindicated in patients with known hypersensitivity to irbesartan or with bilateral renal artery stenosis.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q8\" aria-expanded=\"false\" aria-controls=\"faq-a8\"><span>Which strength and presentation is available?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a8\" role=\"region\" aria-labelledby=\"faq-q8\"><div><p>Vascutan contains irbesartan 300 mg, oral, and comes in a box of 30 or 100 tablets, following the United States Pharmacopeia standard.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q9\" aria-expanded=\"false\" aria-controls=\"faq-a9\"><span>How is Vascutan manufactured?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a9\" role=\"region\" aria-labelledby=\"faq-q9\"><div><p>Vascutan is manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all its products are manufactured in accordance with GMP parameters.<\/p><\/div><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"quality\" id=\"quality\" aria-labelledby=\"qs\">\n  <div class=\"cx-wrap\">\n    <div class=\"qbox rv\">\n      <h2 id=\"qs\">Quality &amp; Standards<\/h2>\n      <div class=\"qgrid\">\n        <img decoding=\"async\" class=\"gmp\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/logo-gmp.png\" alt=\"GMP Certified Quality\" width=\"112\" height=\"112\" title=\"\">\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality.<\/p><\/div>\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.<\/p><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n<\/main>\n\n\n<script>\n(function(){\n  var d=document.documentElement,b=document.body;\n  b.classList.remove('no-js');\n  requestAnimationFrame(function(){requestAnimationFrame(function(){b.classList.add('loaded')})});\n\n  var io=new IntersectionObserver(function(es){es.forEach(function(e){\n    if(e.isIntersecting){e.target.classList.add('in');io.unobserve(e.target)}})},{threshold:.15,rootMargin:'0px 0px -6% 0px'});\n  document.querySelectorAll('.rv').forEach(function(el){io.observe(el)});\n\n\n  (function(){\n    var c=document.getElementById('fx');if(!c||!c.getContext)return;\n    var ctx=c.getContext('2d'),hero=c.parentElement,W=0,H=0,dpr=1,P=[],run=false,raf=0,mx=-999,my=-999;\n    var reduce=matchMedia('(prefers-reduced-motion: reduce)').matches;\n    function size(){var r=hero.getBoundingClientRect();dpr=Math.min(devicePixelRatio||1,2);W=r.width;H=r.height;c.width=W*dpr;c.height=H*dpr;ctx.setTransform(dpr,0,0,dpr,0,0);\n      var n=Math.round(Math.min(90,Math.max(28,W*H\/16000)));P=[];\n      for(var i=0;i<n;i++)P.push({x:Math.random()*W,y:Math.random()*H,vx:(Math.random()-.5)*.28,vy:(Math.random()-.5)*.28,r:Math.random()*1.4+.8});}\n    function draw(){\n      ctx.clearRect(0,0,W,H);var L=Math.min(150,W\/7);\n      for(var i=0;i<P.length;i++){var a=P[i];\n        if(!reduce){a.x+=a.vx;a.y+=a.vy;if(a.x<0||a.x>W)a.vx*=-1;if(a.y<0||a.y>H)a.vy*=-1;\n          var dx=a.x-mx,dy=a.y-my,d=dx*dx+dy*dy;if(d<14400){var f=(1-Math.sqrt(d)\/120)*.6;a.x+=dx*f*.02;a.y+=dy*f*.02}}\n        for(var j=i+1;j<P.length;j++){var b=P[j],ex=a.x-b.x,ey=a.y-b.y,e=ex*ex+ey*ey;\n          if(e<L*L){ctx.strokeStyle='rgba(224,196,236,'+(.22*(1-Math.sqrt(e)\/L))+')';ctx.lineWidth=1;ctx.beginPath();ctx.moveTo(a.x,a.y);ctx.lineTo(b.x,b.y);ctx.stroke()}}\n        ctx.fillStyle='rgba(240,222,247,.75)';ctx.beginPath();ctx.arc(a.x,a.y,a.r,0,6.2832);ctx.fill();}\n      if(run&&!reduce)raf=requestAnimationFrame(draw);}\n    function start(){if(!run){run=true;raf=requestAnimationFrame(draw)}}\n    function stop(){run=false;cancelAnimationFrame(raf)}\n    size();draw();\n    var rt;addEventListener('resize',function(){clearTimeout(rt);rt=setTimeout(function(){size();draw()},150)});\n    hero.addEventListener('pointermove',function(e){var r=hero.getBoundingClientRect();mx=e.clientX-r.left;my=e.clientY-r.top},{passive:true});\n    hero.addEventListener('pointerleave',function(){mx=my=-999});\n    new IntersectionObserver(function(es){es[0].isIntersecting?start():stop()}).observe(hero);\n  })();\n\n  document.querySelectorAll('.faq-q').forEach(function(b){\n    b.addEventListener('click',function(){\n      var it=b.closest('.faq-item'),open=it.classList.toggle('open');\n      b.setAttribute('aria-expanded',open?'true':'false');\n    });\n  });\n  var flow=document.getElementById('flow');\n  var fio=new IntersectionObserver(function(es){es.forEach(function(e){if(e.isIntersecting){flow.classList.add('in');fio.disconnect()}})},{threshold:.25});\n  fio.observe(flow);\n\n  var steps=document.getElementById('steps');\n  function line(){var r=steps.getBoundingClientRect(),h=innerHeight;\n    var p=Math.min(1,Math.max(0,(h*.75-r.top)\/r.height));steps.style.setProperty('--line',p)}\n  addEventListener('scroll',line,{passive:true});line();\n\n})();\n<\/script>\n<\/body>\n<\/html>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Vascutan\u00ae (Irbesartan) \u2013 Crassula Skip to content Angiotensin II Receptor Antagonist \u00b7 Hypertension Vascutan\u00ae Irbesartan 300 mg Pharmacological Properties Active ingredient Irbesartan 300 mg Route Oral Presentation Box of 30 or 100 tablets Standard USP What is Vascutan? Vascutan contains irbesartan, an angiotensin II receptor antagonist, available as tablets for oral administration. It is indicated [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12048","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/comments?post=12048"}],"version-history":[{"count":4,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12048\/revisions"}],"predecessor-version":[{"id":12055,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12048\/revisions\/12055"}],"wp:attachment":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/media?parent=12048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}